RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: pancreatic ductal carcinoma
Accession: DOID:3587
browse the term
Definition: A pancreatic carcinoma located_in the pancreatic duct. (DO)
Synonyms: exact_synonym: Duct Cell Carcinoma of the Pancreas; Pancreas Duct-Cell Carcinoma; Pancreas Duct-Cell Carcinomas; Pancreatic Ductal Carcinomas; ductal carcinoma of the pancreas; malignant neoplasm of duct of Wirsung; pancreatic duct cancer; pancreatic duct cell carcinoma
primary_id: MESH:D021441
xref: ICD10CM:C25.3 ; ICD9CM:157.3
For additional species annotation, visit the
Alliance of Genome Resources .
G
ACE
angiotensin I converting enzyme
ISO
mRNA, protein:increased expression:pancreas
RGD
PMID:17481528
RGD:2325211
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACE2
angiotensin converting enzyme 2
ISO
protein:decreased expression:pancreas
RGD
PMID:19212105
RGD:2325210
NCBI chr X:11,798,839...11,839,591
Ensembl chr X:11,798,839...11,900,594
G
ADAM8
ADAM metallopeptidase domain 8
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:17979891
RGD:2325243
NCBI chr28:40,853,665...40,865,604
Ensembl chr28:40,855,509...40,863,747
G
ADAM9
ADAM metallopeptidase domain 9
disease_progression
ISO
protein:altered localization:cytoplasm
RGD
PMID:14997207
RGD:2325249
NCBI chr16:26,413,345...26,551,293
Ensembl chr16:26,414,583...26,551,122
G
AGR2
anterior gradient 2, protein disulphide isomerase family member
ISO
mRNA:increased expression:pancreas
RGD
PMID:19609859
RGD:2325659
NCBI chr14:31,303,784...31,316,752
Ensembl chr14:31,305,567...31,316,686
G
AGTR1
angiotensin II receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17481528
NCBI chr23:43,569,658...43,617,113
Ensembl chr23:43,614,035...43,616,238
G
ALB
albumin
disease_progression
ISO
RGD
PMID:19011933
RGD:2325677
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
G
ANXA2
annexin A2
disease_progression
ISO
mRNA, protein:increased expression, altered localization:pancreas, plasma membrane
RGD
PMID:16450333 PMID:19260470
RGD:2317307 RGD:2325731
NCBI chr30:25,176,845...25,210,244
Ensembl chr30:25,115,842...25,218,281
G
ANXA5
annexin A5
ISO
protein:increased expression:pancreas
RGD
PMID:19488907
RGD:2317538
NCBI chr19:18,419,936...18,450,088
Ensembl chr19:18,407,587...18,570,378
G
APOC1
apolipoprotein C1
ISO
RGD
PMID:15876873
RGD:2325793
NCBI chr 1:110,520,177...110,522,563
Ensembl chr 1:110,520,198...110,631,412
G
ARG2
arginase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23424623
NCBI chr 8:41,588,051...41,619,406
Ensembl chr 8:41,588,150...41,619,402
G
B9D2
B9 domain containing 2
disease_progression
ISO
RGD
PMID:16101174
RGD:2325019
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
BMI1
BMI1 proto-oncogene, polycomb ring finger
ISO
protein:increased expression:pancreas protein:increased expression:exocrine pancreas:
RGD
PMID:19585519
RGD:9491843
NCBI chr 2:10,818,232...10,828,473
Ensembl chr 2:10,818,232...10,833,613
G
C1H19orf33
chromosome 1 C19orf33 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35142956
NCBI chr 1:114,689,909...114,693,980
G
CALR
calreticulin
ISO
protein:increased expression:pancreatic duct
RGD
PMID:15289361
RGD:2326165
NCBI chr20:49,251,390...49,255,291
Ensembl chr20:49,251,777...49,255,245
G
CBX7
chromobox 7
disease_progression
ISO
protein:decreased expression:pancreas
RGD
PMID:20185297
RGD:9587360
NCBI chr10:25,876,022...25,896,284
Ensembl chr10:25,876,016...25,893,501
G
CCKAR
cholecystokinin A receptor
ISO
mRNA:increased expression:pancreatic duct protein:decreased expression:pancreas
RGD
PMID:9239407 PMID:12851875
RGD:4110816 RGD:4110818
NCBI chr 3:84,010,700...84,019,066
Ensembl chr 3:84,010,205...84,021,293
G
CCKBR
cholecystokinin B receptor
ISO
protein:decreased expression:pancreas
RGD
PMID:12851875
RGD:4110816
NCBI chr21:29,602,066...29,606,343
Ensembl chr21:29,604,150...29,605,725
G
CCND1
cyclin D1
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:17420962
RGD:13462063
NCBI chr18:48,501,905...48,509,684
Ensembl chr18:48,501,899...48,516,005
G
CD40
CD40 molecule
treatment
ISO
protein:increased expression:dendritic cell
RGD
PMID:20976171 PMID:21436454 PMID:23983255
RGD:11522743 RGD:5490301 RGD:5490524
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
CDK6
cyclin dependent kinase 6
treatment
ISO
human cells in a mouse model
RGD
PMID:24389175
RGD:13782187
NCBI chr14:18,178,352...18,413,869
Ensembl chr14:18,188,429...18,419,869
G
CDKN1A
cyclin dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:17671118
RGD:8662851
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
G
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24986516
NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379
G
CLDN4
claudin 4
ISO
RGD
PMID:15693851
RGD:2317592
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
G
CXCL11
C-X-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr32:631,084...636,997
Ensembl chr32:631,478...632,868 Ensembl chr32:631,478...632,868
G
DNMT1
DNA methyltransferase 1
disease_progression
ISO
protein:increased expression:pancreas CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19424621 PMID:29844410
RGD:9588974
NCBI chr20:50,872,213...50,928,352
Ensembl chr20:50,879,527...50,928,029
G
DNMT3B
DNA methyltransferase 3 beta
disease_progression
ISO
RGD
PMID:22919364
RGD:9589121
NCBI chr24:22,096,386...22,123,378
Ensembl chr24:22,096,349...22,122,900
G
DTX1
deltex E3 ubiquitin ligase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr26:10,469,850...10,502,682
G
DTX4
deltex E3 ubiquitin ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr18:37,535,957...37,570,937
Ensembl chr18:37,538,342...37,591,589
G
EGF
epidermal growth factor
disease_progression
ISO
protein:increased expression: :
RGD
PMID:18505086
RGD:2317644
NCBI chr32:30,073,541...30,166,904
Ensembl chr32:30,073,950...30,166,295
G
FASLG
Fas ligand
ISO
protein:increased expression:pancreas, liver
RGD
PMID:10547193 PMID:15375495
RGD:2317741 RGD:2317747
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
G
FGF2
fibroblast growth factor 2
disease_progression
ISO
RGD
PMID:12717266 PMID:18704599
RGD:2317756 RGD:2317758
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
G
FSCN1
fascin actin-bundling protein 1
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:12109856
RGD:2317790
NCBI chr 6:12,360,849...12,370,906
Ensembl chr 6:12,354,599...12,370,808
G
GPNMB
glycoprotein nmb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr14:36,919,184...36,947,023
Ensembl chr14:36,919,296...36,946,643
G
GSTP1
glutathione S-transferase pi 1
resistance
ISO
DNA:methylation: : mRNA, protein:increased expression:pancreas
RGD
PMID:12488200 PMID:16537562 PMID:17265526
RGD:2317806 RGD:2317809 RGD:2317811
NCBI chr18:49,905,161...49,908,182
Ensembl chr18:49,905,161...49,908,182
G
HDAC1
histone deacetylase 1
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:19424621
RGD:9588974
NCBI chr 2:68,901,339...68,936,473
Ensembl chr 2:68,901,651...68,936,186
G
HEATR1
HEAT repeat containing 1
treatment
ISO
RGD
PMID:26676747
RGD:10761108
NCBI chr 4:3,501,191...3,547,212
Ensembl chr 4:3,501,571...3,547,100
G
HES1
hes family bHLH transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
G
HEY1
hes related family bHLH transcription factor with YRPW motif 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr29:27,185,191...27,188,121
Ensembl chr29:27,185,191...27,188,121
G
HEY2
hes related family bHLH transcription factor with YRPW motif 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 1:64,630,656...64,646,546
G
HSP70
heat shock protein 70
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17234771
NCBI chr12:1,285,282...1,287,670
G
IGF1
insulin like growth factor 1
ISO
RGD
PMID:20098680
RGD:2317639
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:increased expression:pancreas
RGD
PMID:14506643 PMID:14627343
RGD:2317649 RGD:2317652
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
IL4
interleukin 4
ISO
RGD
PMID:17942922
RGD:2317264
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
IL4R
interleukin 4 receptor
ISO
protein:increased expression:pancreas
RGD
PMID:17942922
RGD:2317264
NCBI chr 6:19,254,183...19,280,973
Ensembl chr 6:19,254,487...19,389,291
G
INS
insulin
ISO
Glucagon/insulin
RGD
PMID:19571666
RGD:2317248
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
G
JAG1
jagged canonical Notch ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr24:11,656,926...11,693,146
Ensembl chr24:11,657,416...11,692,199
G
JAG2
jagged canonical Notch ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 8:72,535,539...72,553,531
Ensembl chr 8:72,535,107...72,550,322
G
KDM2B
lysine demethylase 2B
severity
ISO
mRNA, protein:increased expression:pancreas (human)
RGD
PMID:23321669
RGD:9588253
NCBI chr26:7,625,857...7,746,049
Ensembl chr26:7,598,931...7,745,113
G
KITLG
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr15:29,591,068...29,671,985
Ensembl chr15:29,591,170...29,671,974
G
KRAS
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25347530 PMID:30654191
NCBI chr27:22,261,753...22,296,704
Ensembl chr27:22,257,941...22,293,369
G
KRT7
keratin 7
disease_progression
ISO
RGD
PMID:19260470
RGD:2317307
NCBI chr27:2,812,709...2,827,451
G
L1CAM
L1 cell adhesion molecule
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:20162456
RGD:6483447
NCBI chr X:121,708,695...121,722,819
Ensembl chr X:121,708,894...121,733,365
G
LOC611363
mesothelin
disease_progression
ISO
protein:increased secretion:serum CTD Direct Evidence: marker/mechanism DNA:hypomethylation:5'UTR
RGD CTD
PMID:12874021 PMID:14576474 PMID:19818733 PMID:21775916 PMID:25347530
RGD:2326055 RGD:2326065
NCBI chr 6:39,827,985...39,834,945
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr12:49,669,849...49,740,039
Ensembl chr12:49,672,389...49,739,850
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
human cells in mouse model
RGD
PMID:20179210
RGD:14348973
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
MCM7
minichromosome maintenance complex component 7
ISO
mRNA, protein:increased expression:pancreatic duct
RGD
PMID:15548371
RGD:2317697
NCBI chr 6:9,492,654...9,499,846
Ensembl chr 6:9,492,573...9,499,855
G
MDM2
MDM2 proto-oncogene
severity onset
ISO
protein:increased expression:pancreas (human) DNA:snp:promoter, intron:IVS1+309T>G (human)
RGD
PMID:15810085 PMID:19752772
RGD:2317414 RGD:2317416
NCBI chr10:10,936,288...10,963,118
Ensembl chr10:10,893,719...10,962,596
G
MEN1
menin 1
ISO
protein:decreased expression:pancreas
RGD
PMID:19170121
RGD:2317294
NCBI chr18:52,346,747...52,352,884
Ensembl chr18:52,346,933...52,353,340
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
protein:increased expression:pancreatic duct (human)
RGD
PMID:7866999
RGD:2317530
NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027
G
MGMT
O-6-methylguanine-DNA methyltransferase
susceptibility
ISO
protein:increased activity, increased expression:ductal adenocarcinoma (human) DNA:missense mutation:cds:p.L84F rs12917 (human)
RGD
PMID:9393761 PMID:16844323
RGD:2317648 RGD:2317664
NCBI chr28:38,204,611...38,427,482
Ensembl chr28:38,204,610...38,427,380
G
MIR142
microRNA mir-142
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29844410
NCBI chr 9:32,977,393...32,977,455
Ensembl chr 9:32,977,382...32,977,468
G
MMP2
matrix metallopeptidase 2
severity
ISO
protein:increased expression:pancreas
RGD
PMID:17377415
RGD:2325746
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased expression:blood protein:increased expression:pancreas, serum
RGD
PMID:18706098 PMID:20332475
RGD:2325830 RGD:2325844
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MUC1
mucin 1, cell surface associated
disease_progression
ISO
protein:increased expression, altered localization:pancreas
RGD
PMID:14681945 PMID:18713982 PMID:19109152
RGD:2317983 RGD:2324616 RGD:2324633
NCBI chr 7:42,338,939...42,344,690
Ensembl chr 7:42,340,375...42,344,690
G
MUC4
mucin 4, cell surface associated
disease_progression
ISO
mRNA:increased expression:pancreas protein:increased expression:pancreas
RGD
PMID:12657964 PMID:16049287
RGD:2324942 RGD:2324946
NCBI chr33:29,061,372...29,084,938
Ensembl chr33:29,063,096...29,111,802
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:7657125 PMID:10227724
RGD:2324907 RGD:2324986
NCBI chr18:45,471,232...45,498,961
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
ISO
mRNA:increased expression:pancreas
RGD
PMID:7657125
RGD:2324986
NCBI chr18:45,517,479...45,545,765
Ensembl chr18:45,517,474...45,545,184
G
NDRG1
N-myc downstream regulated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16778198
NCBI chr13:29,689,294...29,745,964
Ensembl chr13:29,650,444...29,746,382
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21489257
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NME1
non-metastatic cells 1, protein (NM23A) expressed in
ISO
protein:increased expression:pancreas (human)
RGD
PMID:17492507
RGD:5132867
NCBI chr 9:26,990,336...26,998,895
Ensembl chr 9:26,990,469...26,998,955
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:12660813
RGD:2325254
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOTCH1
notch receptor 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19028876 PMID:19208345 PMID:20484026
RGD:2325323 RGD:2325324
NCBI chr 9:48,975,972...49,018,985
Ensembl chr 9:48,974,757...49,017,277
G
NOTCH3
notch receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr20:46,946,654...46,978,821
Ensembl chr20:46,937,485...46,978,219
G
NOTCH4
notch receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr12:1,585,249...1,608,721
Ensembl chr12:1,587,918...1,607,760
G
NTRK3
neurotrophic receptor tyrosine kinase 3
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:10209957 PMID:11295066
RGD:2325660 RGD:2325663
NCBI chr 3:51,131,470...51,491,112
Ensembl chr 3:51,138,751...51,513,024
G
OSM
oncostatin M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr26:23,421,787...23,439,332
Ensembl chr26:23,421,787...23,426,036
G
PALLD
palladin, cytoskeletal associated protein
ISO
protein:increased expression, alternative form:pancreas, fibroblast
RGD
PMID:17404500
RGD:2325781
NCBI chr25:19,147,310...19,568,712
Ensembl chr25:19,146,898...19,553,679
G
PAX6
paired box 6
ISO
protein:increased expression:pancreatic duct (human)
RGD
PMID:17849422
RGD:8552381
G
PMS1
PMS1 homolog 1, mismatch repair system component
ISO
protein:increased expression:pancreatic duct
RGD
PMID:15856462
RGD:2324870
NCBI chr37:502,752...609,640
Ensembl chr37:502,747...790,904
G
PPARG
peroxisome proliferator activated receptor gamma
disease_progression
ISO
RGD
PMID:19396032
RGD:2317461
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:18670639
RGD:2317185
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
RNF2
ring finger protein 2
ISO
protein:increased expression:pancreas
RGD
PMID:19585519
RGD:9491843
NCBI chr 7:18,240,672...18,283,091
Ensembl chr 7:18,236,115...18,281,387
G
RXRA
retinoid X receptor alpha
severity
ISO
RGD
PMID:19396032
RGD:2317461
NCBI chr 9:50,525,195...50,575,720
Ensembl chr 9:50,484,567...50,573,119
G
SERPINA1
serpin family A member 1
ISO
mRNA, protein:increased expression:pancreas
RGD
PMID:12488200
RGD:2317811
NCBI chr 8:63,388,498...63,400,377
Ensembl chr 8:63,376,945...63,398,435
G
SLC2A2
solute carrier family 2 member 2
ISO
protein:increased expression:pancreatic duct
RGD
PMID:19252908
RGD:2324975
NCBI chr34:35,368,583...35,398,197
Ensembl chr34:35,370,192...35,400,409
G
SMAD4
SMAD family member 4
disease_progression
ISO
RGD
PMID:15173084
RGD:21066334
NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405
G
SMO
smoothened, frizzled class receptor
ISO
RGD
PMID:16826192
RGD:2324981
NCBI chr14:7,518,871...7,527,703
Ensembl chr14:7,518,856...7,528,033
G
STK11
serine/threonine kinase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26887594
NCBI chr20:57,558,966...57,579,163
Ensembl chr20:57,559,424...57,579,118
G
TGFBR2
transforming growth factor beta receptor 2
disease_progression
ISO
mRNA:increased expresssion:pancreas
RGD
PMID:10547197 PMID:17114585
RGD:2317498 RGD:2317500
NCBI chr23:13,886,869...13,946,480
Ensembl chr23:13,889,000...13,977,636
G
THBS1
thrombospondin 1
disease_progression
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:12429967 PMID:19065635
RGD:2325022 RGD:2325025
NCBI chr30:6,770,212...6,786,875
Ensembl chr30:6,769,470...6,784,915
G
TMPRSS3
transmembrane serine protease 3
ISO
RGD
PMID:14695172
RGD:2325152
NCBI chr31:36,706,229...36,730,444
Ensembl chr31:36,707,723...36,730,520
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29844410
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
TSC2
TSC complex subunit 2
severity
ISO
RGD
PMID:16213898
RGD:11568674
NCBI chr 6:38,865,509...38,898,977
Ensembl chr 6:38,865,507...38,898,960
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17481528
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VHL
von Hippel-Lindau tumor suppressor
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:19065635
RGD:2325022
NCBI chr20:8,206,616...8,211,347
Ensembl chr20:8,206,616...8,211,323
G
YEATS2
YEATS domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr34:16,654,672...16,777,493
Ensembl chr34:16,654,493...16,777,506
G
ZZZ3
zinc finger ZZ-type containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 6:69,180,465...69,278,740
Ensembl chr 6:69,180,349...69,277,596
G
TGFB2
transforming growth factor beta 2
ameliorates
ISO
human cells in a mouse model
RGD
PMID:21366804
RGD:155630611
NCBI chr38:13,430,832...13,511,655
Ensembl chr38:13,429,148...13,510,242
G
AGR2
anterior gradient 2, protein disulphide isomerase family member
ISO
protein:increased expression:pancreas
RGD
PMID:19714807
RGD:2325658
NCBI chr14:31,303,784...31,316,752
Ensembl chr14:31,305,567...31,316,686
G
AKR7A2
aldo-keto reductase family 7 member A2
ISO
protein:increased expression:pancreas
RGD
PMID:19077459
RGD:2325696
NCBI chr 2:79,334,179...79,343,880
Ensembl chr 2:79,334,205...79,343,007
G
B9D2
B9 domain containing 2
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
CALR
calreticulin
ameliorates
ISO
human cells in mouse model human cells in a mouse model
RGD
PMID:29072694 PMID:33028359
RGD:150520160 RGD:150521706
NCBI chr20:49,251,390...49,255,291
Ensembl chr20:49,251,777...49,255,245
G
CCND1
cyclin D1
severity
ISO
protein:increased expression:pancreas (human) DNA:snp:exon:c.870G>A (human)
RGD
PMID:22939953 PMID:25470788
RGD:13462050 RGD:13462062
NCBI chr18:48,501,905...48,509,684
Ensembl chr18:48,501,899...48,516,005
G
CD59
CD59 molecule
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr18:33,977,433...33,999,145
Ensembl chr18:33,977,480...33,998,329
G
CDK4
cyclin dependent kinase 4
severity
ISO
protein:increased expression:pancreas, islet of Langerhans (human)
RGD
PMID:29735403
RGD:13781899
NCBI chr10:1,812,864...1,815,815
Ensembl chr10:1,812,886...1,815,789
G
E2F1
E2F transcription factor 1
severity
ISO
protein:increased expression:pancreatic ductal cell, nucleus (human) DNA:amplification: : (human)
RGD
PMID:12650514 PMID:17233815 PMID:27573434
RGD:13838735 RGD:13838738 RGD:13838739
NCBI chr24:22,895,149...22,904,689
Ensembl chr24:22,878,402...22,904,656
G
FOXM1
forkhead box M1
disease_progression
ISO
RGD
PMID:24859161
RGD:156430321
NCBI chr27:41,894,605...41,905,656
Ensembl chr27:41,894,672...41,905,663
G
FUBP1
far upstream element binding protein 1
ISO
mRNA:increased expression:pancreatic duct (human)
RGD
PMID:32481602
RGD:151361197
NCBI chr 6:68,923,215...68,963,766
G
GLIPR2
GLI pathogenesis related 2
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr11:52,622,460...52,634,602
Ensembl chr11:52,615,039...52,681,270
G
GOT1
glutamic-oxaloacetic transaminase 1
treatment
ISO
human cells in a mouse model
RGD
PMID:23535601
RGD:13504844
NCBI chr28:12,352,658...12,377,960
Ensembl chr28:12,352,659...12,414,579
G
HSPA8
heat shock protein family A (Hsp70) member 8
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 5:11,292,219...11,296,851
Ensembl chr 5:11,292,262...11,296,797
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
susceptibility
ISO
RGD
PMID:22264792
RGD:13838741
NCBI chr16:23,359,551...23,419,114
Ensembl chr16:23,359,813...23,419,075
G
JAK1
Janus kinase 1
ISO
mRNA:decreased expression:pancreatic ductal cell (human)
RGD
PMID:28677798
RGD:13838745
NCBI chr 5:45,251,653...45,408,571
Ensembl chr 5:45,251,653...45,408,571
G
MAPK8
mitogen-activated protein kinase 8
disease_progression severity
ISO
protein:increased phosphorylation:pancreas (mouse)
RGD
PMID:23237571 PMID:28837246
RGD:14348974 RGD:14348975
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
G
MIR155
microRNA mir-155
disease_progression
ISO
RGD
PMID:28198398
RGD:25314300
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR494
microRNA mir-494
ameliorates disease_progression
ISO
RGD
PMID:24859161
RGD:156430321
NCBI chr 8:69,261,385...69,261,465
Ensembl chr 8:69,261,385...69,261,465
G
PGF
placental growth factor
severity
ISO
associated with obesity
RGD
PMID:26861455
RGD:14349030
NCBI chr 8:48,059,554...48,110,534
Ensembl chr 8:48,059,552...48,075,170
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
mRNA, protein:increased expression:pancreas (human)
RGD
PMID:20876794
RGD:14390130
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PIK3R2
phosphoinositide-3-kinase regulatory subunit 2
severity
ISO
human cells in a mouse model
RGD
PMID:15591514
RGD:14390084
NCBI chr20:44,826,037...44,838,449
Ensembl chr20:44,826,339...44,836,558
G
PLD1
phospholipase D1
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:27713167
RGD:14392801
NCBI chr34:35,917,759...36,080,383
Ensembl chr34:35,921,058...36,121,631
G
PTPRB
protein tyrosine phosphatase receptor type B
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr10:12,267,891...12,384,522
Ensembl chr10:12,241,716...12,384,435
G
PTPRM
protein tyrosine phosphatase receptor type M
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 7:74,005,682...74,597,498
Ensembl chr 7:73,815,186...74,609,116
G
RAC1
Rac family small GTPase 1
ISO
mRNA:increased expression:pancreas (human) mRNA, protein:increased expression:pancreas (mouse)
RGD
PMID:21684285 PMID:23334332
RGD:14392806 RGD:14392816
NCBI chr 6:11,726,259...11,758,532
Ensembl chr 6:11,655,494...11,757,216
G
RALA
RAS like proto-oncogene A
ISO
mRNA:increased expression:pancreas (human)
RGD
PMID:29113235
RGD:14394418
NCBI chr18:10,022,490...10,047,583
Ensembl chr18:10,024,311...10,039,183
G
S100A8
S100 calcium binding protein A8
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 7:43,540,667...43,541,604
Ensembl chr 7:43,501,989...43,541,604
G
SMAD2
SMAD family member 2
severity
ISO
RGD
PMID:26908446
RGD:14394493
NCBI chr 7:43,696,883...43,778,063
Ensembl chr 7:43,700,445...43,769,983
G
TGFB2
transforming growth factor beta 2
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr38:13,430,832...13,511,655
Ensembl chr38:13,429,148...13,510,242
G
TGFB3
transforming growth factor beta 3
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr 8:48,920,874...48,946,037
Ensembl chr 8:48,923,423...48,945,816
G
TGFBR1
transforming growth factor beta receptor 1
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:17297450
RGD:155630637
NCBI chr11:56,191,383...56,223,042
Ensembl chr11:56,161,772...56,218,594
G
VEGFD
vascular endothelial growth factor D
ISO
protein:increased expression:blood serum (human)
RGD
PMID:21410412
RGD:155630646
NCBI chr X:11,590,097...11,627,199
Ensembl chr X:11,590,089...11,626,486
G
VNN1
vanin 1
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 1:25,678,039...25,704,579
Ensembl chr 1:25,678,042...25,696,807
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all